Veterinary Medicines

Enteroporc AC Lyophilisate and solvent for suspension for injection for pigs

Not authorised
  • Clostridium perfringens, type A and C, alpha toxoid
  • Clostridium perfringens, type A, beta2 toxoid
  • Clostridium perfringens, type C, beta1 toxoid
Download as PDF

Product identification

Medicine name:
Enteroporc AC Lyophilisate and solvent for suspension for injection for pigs
Active substance:
  • Clostridium perfringens, type A and C, alpha toxoid
  • Clostridium perfringens, type A, beta2 toxoid
  • Clostridium perfringens, type C, beta1 toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Clostridium perfringens, type A and C, alpha toxoid
  • Clostridium perfringens, type A, beta2 toxoid
  • Clostridium perfringens, type C, beta1 toxoid
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • (ID8): 1 Box with 40 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (1000.0 Dose, 2000.0 millilitre(s))
  • (ID7): 1 Box with 20 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (500.0 Dose, 1000.0 millilitre(s))
  • (ID6): 1 Box with 10 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (250.0 Dose, 500.0 millilitre(s))
  • (ID5): 1 Box with 4 Box with (1 Bottle (Glass) with 50 millilitre(s) and 1 Bottle (Glass) with 25 Dose) (200.0 millilitre(s), 100.0 Dose)
  • (ID4): 1 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (25.0 Dose, 50.0 millilitre(s))
  • (ID3): 1 Box with 10 Box with (1 Bottle (Glass) with 20 millilitre(s) and 1 Bottle (Glass) with 10 Dose) (200.0 millilitre(s), 100.0 Dose)
  • (ID2): 1 Box with 5 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (50.0 Dose, 100.0 millilitre(s))
  • (ID1): 1 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (10.0 Dose, 20.0 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Idt Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10524/006/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0271/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."